Abietic Acid
CAS 514-10-3
Abietic Acid (CAS 514-10-3) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 55716.76050847458 nM | 59 | - |
| - | IC50 | 53056.6 nM | 6 | - |
| - | MIC | 35 ug.mL-1 | 5 | - |
| - | Potency | 28059.960000000003 nM | 5 | - |
| - | IC50 | 25 ug.mL-1 | 2 | - |
| - | Ki | 2775 nM | 2 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Abietic Acid used for in pharmaceutical contexts?
Abietic Acid (CAS 514-10-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Abietic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Abietic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Abietic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Abietic Acid with EU status "permitted".
What clinical phase is Abietic Acid in?
No phase 1-4 clinical development badge is rendered for Abietic Acid because the matched compound identifier rows do not contain a max-phase value.